0001179110-19-001519.txt : 20190207
0001179110-19-001519.hdr.sgml : 20190207
20190207164104
ACCESSION NUMBER: 0001179110-19-001519
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190205
FILED AS OF DATE: 20190207
DATE AS OF CHANGE: 20190207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scadden David
CENTRAL INDEX KEY: 0001707715
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37687
FILM NUMBER: 19575669
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Editas Medicine, Inc.
CENTRAL INDEX KEY: 0001650664
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464097528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-401-9000
MAIL ADDRESS:
STREET 1: 11 HURLEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
edgar.xml
FORM 4 -
X0306
4
2019-02-05
0
0001650664
Editas Medicine, Inc.
EDIT
0001707715
Scadden David
C/O EDITAS MEDICINE, INC.
11 HURLEY ST.
CAMBRIDGE
MA
02141
1
0
0
0
Stock Option (right to buy)
21.14
2019-02-05
4
A
0
23076
0
A
2029-02-04
Common Stock
23076
23076
D
This option was granted on February 5, 2019 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on February 5, 2020 through February 5, 2022.
/s/ David Scadden
2019-02-07